I think we'll see a decent lift this quarter in sales although am expecting to see sales really take off in the March quarter with the release of CardioCel3D... 3D is a revolutionary product, a one off its kind, surgeons love using it and 85% of surgeons surveyed said they'd start using it immediately. Wayne has forecast a 130% rise in ADAPT sales in CY18 (from memory) although I think there's a great chance we'll see higher.
Under the Radar, page-11
-
- There are more pages in this discussion • 528 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |